SITC Cancer Immunotherapy CONNECT

Welcome to the Society for Immunotherapy of Cancer.

Our mission is to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy.

Don't miss us in National Harbor, MD for SITC 2025, our 40^th Anniversary Annual Meeting & Pre-Conference Programs. Visit our SITC 2025 site for the latest information on abstracts, registration, and more.

Visit the SITC 2025 Site

SITC Biotech Strategic Meeting at the NYSE

Friday, June 27, 2025, from 9 A.M.–2 P.M. ET

This exclusive event will bring together experts, investors, and biotech innovators to discuss the future of T-cell engagers, China’s impact on IO clinical research, and strategic pathways for novel immunotherapy advancements.

Learn more & register >

A New Interview Series from SITC

From Conception to Launch to Funding: Spinning Technology from Academia to Biotech

In this insightful interview, leading experts, Dr. Bruce Levine (Founding Director, Clinical Cell and Vaccine Production Facility at the Perelman School of Medicine at the University of Pennsylvania) and Dr. Samir Khleif (founder and CEO of Georgiamune) discuss the evolving landscape of academic innovation and tech transfer in oncology, immunotherapy, and biotech commercialization.

Watch the interview >

Learn from clinical experts with the 2025 Advances in Cancer Immunotherapy (ACI) Series

ACI programs are certified for CME credits and are free for healthcare professionals, students, patients and patient advocates.

Join A Focus on Gastrointestinal Cancers April 23. New focus points for this year include a discussion of recent developments and ongoing studies of adoptive cellular therapies for gastrointestinal cancers.

Learn More >

Improve your training with the SITC-NCI Computational Immuno-oncology Webinar Series

This year's series will focus specifically on advanced methods and clinical utility for biomarker development in IO.

Stay abreast of the latest technologies - register today for the entire series of ten FREE webinars from SITC.

Learn from key leaders in the field at the Targets for Cancer IO: A Deep Dive Live Webinar Series

This series will include six live webinars addressing various hot topics in immuno-oncology.

An interactive Q&A session will follow the topic overview, providing the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.

SITC Statement on NIH Cuts to Indirect Costs

Read the Statement

Browse our other events

2025 ACI: A Focus on Gastrointestinal Cancers

April 23, 2025 | 1–5 p.m. EDT | Virtual

Discuss recent developments and ongoing studies of adoptive cellular therapies for gastrointestinal cancers. Improve patient outcomes with cutting-edge insights from clinical experts!

Lunit Research Program

Exclusively for SITC Members | Applications due April 30

This Lunit research program aims to enhance studies led by SITC members by enabling the use of AI for TME profiling, including quantitative immune phenotyping (IP) via three IP classification: inflamed, excluded and desert.

Learn more

2025 ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines

May 8, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines!

Guidelines and Best Practices on Designing Clinical Trials with Exploratory Surrogate Endpoints and CDX: Computational Science in Immuno-oncology

May 8 | 2:15–3:45 p.m. ET | Virtual

Explore how these guidelines and best practices can shape the future of clinical trials and drive progress in immunotherapy!

A Deep Dive into T-cell Engagers and Targeted Immune Modulation for Prostate Cancer

May 12 | 11 a.m.–1 p.m. ET | Virtual

This webinar will address lessons learned from past studies of T cell engagers and immune modulators for solid tumors and how these insights have informed the identification and testing of these therapies.

2025 ACI: A Focus on Cellular Therapies, T Cell Engagers and TIL Therapies

June 27, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T cell engagers and TIL Therapies.

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

Upcoming SITC Events

Wednesday

23

April

2025 ACI: A Focus on Gastrointestinal Cancers

Apr 23, 13:00 - 17:00 (ET)
Friday

25

April

American Association for Cancer Research (AACR) Annual Meeting 2025

Apr 25 - 30, (CT)

Chicago, IL, United States
Sunday

4

May

SITC Session at IMMUNOLOGY 2025 (AAI Annual Meeting)

May 4, 07:00 - 08:30 (HAST)

Honolulu, HI, United States
Thursday

8

May

2025 ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines

May 8, 11:00 - 15:00 (ET)
Thursday

8

May

Guidelines and Best Practices on Designing Clinical Trials with Exploratory Surrogate Endpoints and

May 8, 14:15 - 15:45 (ET)

Explore More Events

Read the Latest SITC News

JITC Digest April 2025

posted 2 days ago

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...